News

No items found.

July 25, 2022

Valera Health and Horizon Healthcare Services Collaborate to Increase Access to Mental Health Care in New Jersey

July 25, 2022

Valera Health and Horizon Healthcare Services Collaborate to Increase Access to Mental Health Care in New Jersey

No items found.

July 18, 2022

Delfi Diagnostics Announces $225 Million Series B Financing to Develop Globally Accessible Portfolio of Liquid Biopsy Tests

July 18, 2022

Delfi Diagnostics Announces $225 Million Series B Financing to Develop Globally Accessible Portfolio of Liquid Biopsy Tests

No items found.

June 14, 2022

Neuspera Medical® Announces Second Phase of SANS-UUI IDE Clinical Trial with the Nuvella™ System

June 14, 2022

Neuspera Medical® Announces Second Phase of SANS-UUI IDE Clinical Trial with the Nuvella™ System

No items found.

May 9, 2022

CVRx® Receives MR-Conditional Labeling Approval for its Barostim™ Heart Failure System

May 9, 2022

CVRx® Receives MR-Conditional Labeling Approval for its Barostim™ Heart Failure System

No items found.

May 9, 2022

Delfi Diagnostics Initiates 15,000-Patient Prospective Lung Cancer Screening Trial

May 9, 2022

Delfi Diagnostics Initiates 15,000-Patient Prospective Lung Cancer Screening Trial

No items found.

May 5, 2022

Revelle Aesthetics Unveils New Minimally Invasive Procedure for Cellulite Reduction…

May 5, 2022

Revelle Aesthetics Unveils New Minimally Invasive Procedure for Cellulite Reduction…

No items found.

January 25, 2022

200th Treatment Milestone for AIRFLOW-3 COPD Trial

January 25, 2022

200th Treatment Milestone for AIRFLOW-3 COPD Trial

No items found.

December 23, 2021

Labcorp Strengthens Oncology Leadership Position With the Addition of Personal Genome Diagnostics, a Provider of Comprehensive Liquid Biopsy and Tissue-Based Genomic Products and Services

December 23, 2021

Labcorp Strengthens Oncology Leadership Position With the Addition of Personal Genome Diagnostics, a Provider of Comprehensive Liquid Biopsy and Tissue-Based Genomic Products and Services

No items found.

December 16, 2021

Cerebral and Alto Neuroscience Enter into Strategic Collaboration to Launch First-Ever Decentralized Study in Precision Psychiatry

December 16, 2021

Cerebral and Alto Neuroscience Enter into Strategic Collaboration to Launch First-Ever Decentralized Study in Precision Psychiatry

No items found.

November 4, 2021

Valera Health Secures $15M Led by Windham Venture Partners to Expand the Company's Mental Health Clinical Services Across the U.S.

November 4, 2021

Valera Health Secures $15M Led by Windham Venture Partners to Expand the Company's Mental Health Clinical Services Across the U.S.

No items found.

October 14, 2021

Alto Neuroscience Emerges with Largest Clinical-Stage Precision Psychiatry Pipeline and $40 Million in Financing

October 14, 2021

Alto Neuroscience Emerges with Largest Clinical-Stage Precision Psychiatry Pipeline and $40 Million in Financing

No items found.

October 7, 2021

Doug Schenkel Joins Delfi Diagnostics as Chief Financial Officer

October 7, 2021

Doug Schenkel Joins Delfi Diagnostics as Chief Financial Officer

No items found.

September 22, 2021

Clever Care Health Plan Raises Over $71 Million in Series B Funding to Accelerate Growth of its Medicare Advantage HMO Plan

September 22, 2021

Clever Care Health Plan Raises Over $71 Million in Series B Funding to Accelerate Growth of its Medicare Advantage HMO Plan

No items found.

September 17, 2021

CVRx Added to Russell 2000® and 3000® Indexes

September 17, 2021

CVRx Added to Russell 2000® and 3000® Indexes

No items found.

August 11, 2021

Nuvaira Announces AIRFLOW-3 COPD Pivotal Trial Milestone

August 11, 2021

Nuvaira Announces AIRFLOW-3 COPD Pivotal Trial Milestone

No items found.

July 20, 2021

Neuspera Medical Announces Close of a $65M Series C Equity Financing

July 20, 2021

Neuspera Medical Announces Close of a $65M Series C Equity Financing

No items found.

June 29, 2021

CVRx, Inc. Announces Upsized Pricing of Initial Public Offering

June 29, 2021

CVRx, Inc. Announces Upsized Pricing of Initial Public Offering

No items found.

June 15, 2021

Personal Genome Diagnostics Enters Collaborative Partnership with Clinical Molecular Diagnostics Laboratory of Major University Health System

June 15, 2021

Personal Genome Diagnostics Enters Collaborative Partnership with Clinical Molecular Diagnostics Laboratory of Major University Health System

No items found.

June 10, 2021

Upward Health Announces Contract with Clover Health to Serve Patients In Four States Under New Direct Contracting Initiative

June 10, 2021

Upward Health Announces Contract with Clover Health to Serve Patients In Four States Under New Direct Contracting Initiative

No items found.

April 21, 2021

FemTech Leader Willow® Adds Diverse Set Of Investors In Extended Series C Round

April 21, 2021

FemTech Leader Willow® Adds Diverse Set Of Investors In Extended Series C Round

No items found.

March 31, 2021

Delfi Diagnostics Begins Enrollment for Prospective Lung Cancer Screening Trial ahead of Planned Commercial Test

March 31, 2021

Delfi Diagnostics Begins Enrollment for Prospective Lung Cancer Screening Trial ahead of Planned Commercial Test

No items found.

March 16, 2021

ChromaCode Selected as a Winner of $6M XPRIZE Rapid COVID Testing Competition

March 16, 2021

ChromaCode Selected as a Winner of $6M XPRIZE Rapid COVID Testing Competition

No items found.

March 4, 2021

Growing Medication Management Optimization Company, Cureatr, Names New Executive Leadership

March 4, 2021

Growing Medication Management Optimization Company, Cureatr, Names New Executive Leadership

No items found.

March 4, 2021

ControlRad® Announces FDA Clearance for ControlRad Select

March 4, 2021

We are investing in the future of healthcare, see our most recent news.

Valera Health and Horizon Healthcare Services Collaborate to Increase Access to Mental Health Care in New Jersey

Valera Health and Horizon Healthcare Services Collaborate to Increase Access to Mental Health Care in New Jersey

Delfi Diagnostics Announces $225 Million Series B Financing to Develop Globally Accessible Portfolio of Liquid Biopsy Tests

Delfi Diagnostics Announces $225 Million Series B Financing to Develop Globally Accessible Portfolio of Liquid Biopsy Tests

Neuspera Medical® Announces Second Phase of SANS-UUI IDE Clinical Trial with the Nuvella™ System

Neuspera Medical® Announces Second Phase of SANS-UUI IDE Clinical Trial with the Nuvella™ System

CVRx® Receives MR-Conditional Labeling Approval for its Barostim™ Heart Failure System

CVRx® Receives MR-Conditional Labeling Approval for its Barostim™ Heart Failure System

Delfi Diagnostics Initiates 15,000-Patient Prospective Lung Cancer Screening Trial

Delfi Diagnostics Initiates 15,000-Patient Prospective Lung Cancer Screening Trial

Revelle Aesthetics Unveils New Minimally Invasive Procedure for Cellulite Reduction…

Revelle Aesthetics Unveils New Minimally Invasive Procedure for Cellulite Reduction…

200th Treatment Milestone for AIRFLOW-3 COPD Trial

200th Treatment Milestone for AIRFLOW-3 COPD Trial

Labcorp Strengthens Oncology Leadership Position With the Addition of Personal Genome Diagnostics, a Provider of Comprehensive Liquid Biopsy and Tissue-Based Genomic Products and Services

Labcorp Strengthens Oncology Leadership Position With the Addition of Personal Genome Diagnostics, a Provider of Comprehensive Liquid Biopsy and Tissue-Based Genomic Products and Services

Cerebral and Alto Neuroscience Enter into Strategic Collaboration to Launch First-Ever Decentralized Study in Precision Psychiatry

Cerebral and Alto Neuroscience Enter into Strategic Collaboration to Launch First-Ever Decentralized Study in Precision Psychiatry

Valera Health Secures $15M Led by Windham Venture Partners to Expand the Company's Mental Health Clinical Services Across the U.S.

Valera Health Secures $15M Led by Windham Venture Partners to Expand the Company's Mental Health Clinical Services Across the U.S.

Alto Neuroscience Emerges with Largest Clinical-Stage Precision Psychiatry Pipeline and $40 Million in Financing

Alto Neuroscience Emerges with Largest Clinical-Stage Precision Psychiatry Pipeline and $40 Million in Financing

Doug Schenkel Joins Delfi Diagnostics as Chief Financial Officer

Doug Schenkel Joins Delfi Diagnostics as Chief Financial Officer

Clever Care Health Plan Raises Over $71 Million in Series B Funding to Accelerate Growth of its Medicare Advantage HMO Plan

Clever Care Health Plan Raises Over $71 Million in Series B Funding to Accelerate Growth of its Medicare Advantage HMO Plan

CVRx Added to Russell 2000® and 3000® Indexes

CVRx Added to Russell 2000® and 3000® Indexes

Nuvaira Announces AIRFLOW-3 COPD Pivotal Trial Milestone

Nuvaira Announces AIRFLOW-3 COPD Pivotal Trial Milestone

Neuspera Medical Announces Close of a $65M Series C Equity Financing

Neuspera Medical Announces Close of a $65M Series C Equity Financing

CVRx, Inc. Announces Upsized Pricing of Initial Public Offering

CVRx, Inc. Announces Upsized Pricing of Initial Public Offering

Personal Genome Diagnostics Enters Collaborative Partnership with Clinical Molecular Diagnostics Laboratory of Major University Health System

Personal Genome Diagnostics Enters Collaborative Partnership with Clinical Molecular Diagnostics Laboratory of Major University Health System

Upward Health Announces Contract with Clover Health to Serve Patients In Four States Under New Direct Contracting Initiative

Upward Health Announces Contract with Clover Health to Serve Patients In Four States Under New Direct Contracting Initiative

FemTech Leader Willow® Adds Diverse Set Of Investors In Extended Series C Round

FemTech Leader Willow® Adds Diverse Set Of Investors In Extended Series C Round

Delfi Diagnostics Begins Enrollment for Prospective Lung Cancer Screening Trial ahead of Planned Commercial Test

Delfi Diagnostics Begins Enrollment for Prospective Lung Cancer Screening Trial ahead of Planned Commercial Test

ChromaCode Selected as a Winner of $6M XPRIZE Rapid COVID Testing Competition

ChromaCode Selected as a Winner of $6M XPRIZE Rapid COVID Testing Competition

Growing Medication Management Optimization Company, Cureatr, Names New Executive Leadership

Growing Medication Management Optimization Company, Cureatr, Names New Executive Leadership

ControlRad® Announces FDA Clearance for ControlRad Select

ControlRad® Announces FDA Clearance for ControlRad Select